Pricing Log in Create free account

Azora Therapeutics, Inc. (AZR) vs GT Biopharma, Inc. (GTBP)

Azora Therapeutics, Inc. and GT Biopharma, Inc. are both Biotechnology companies. Azora Therapeutics, Inc. and GT Biopharma, Inc. are of similar size ($9.7M and $9.4M). Azora Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; GT Biopharma, Inc. trades at 0.8×. Across the 8 metrics below, Azora Therapeutics, Inc. leads on 4 and GT Biopharma, Inc. on 4.

Valuation

Metric AZR GTBP Biotechnology median
P/E n/m 0.81 10.26
P/S n/m 121.89 9.18
P/B n/m 2.05 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.19 n/m 0.65
EV/Sales n/m 482.71 8.98
Earnings yield (433.06%) 122.77% (34.89%)
Free cash flow yield (62.39%) (194.98%) (24.52%)

Profitability

Metric AZR GTBP Biotechnology median
Gross margin 0.00% 41.67% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 352.60% 102.03% (50.12%)
Return on assets (322.10%) (176.27%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AZR GTBP Biotechnology median
Revenue growth (TTM) — (76.19%) 6.26%
EPS growth (last fiscal year) 82.46% 3.75% 29.88%
Revenue growth, 5-year CAGR — 19.67% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AZR GTBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 2.61 4.89
Net debt to EBITDA 0.75 0.56 1.01

Dividend

Metric AZR GTBP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZR GTBP Biotechnology median
Market cap 9.74m 9.36m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack